These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35114994)

  • 1. Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development.
    Munblit D; Nicholson TR; Needham DM; Seylanova N; Parr C; Chen J; Kokorina A; Sigfrid L; Buonsenso D; Bhatnagar S; Thiruvengadam R; Parker AM; Preller J; Avdeev S; Klok FA; Tong A; Diaz JV; Groote W; Schiess N; Akrami A; Simpson F; Olliaro P; Apfelbacher C; Rosa RG; Chevinsky JR; Saydah S; Schmitt J; Guekht A; Gorst SL; Genuneit J; Reyes LF; Asmanov A; O'Hara ME; Scott JT; Michelen M; Stavropoulou C; Warner JO; Herridge M; Williamson PR
    BMC Med; 2022 Feb; 20(1):50. PubMed ID: 35114994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Respiratory Post-Acute Sequelae of COVID-19 (PASC) and the Potential Benefits of Pulmonary Rehabilitation.
    Simon M; Simmons JE
    R I Med J (2013); 2022 Sep; 105(7):11-15. PubMed ID: 35930484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).
    Pretorius E; Venter C; Laubscher GJ; Kotze MJ; Oladejo SO; Watson LR; Rajaratnam K; Watson BW; Kell DB
    Cardiovasc Diabetol; 2022 Aug; 21(1):148. PubMed ID: 35933347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.
    Kuut TA; Müller F; Aldenkamp A; Assmann-Schuilwerve E; Braamse A; Geerlings SE; Gibney KB; Kanaan RAA; Nieuwkerk P; Olde Hartman TC; Pauëlsen D; Prins M; Slieker K; Van Vugt M; Bleeker-Rovers CP; Keijmel SP; Knoop H
    Trials; 2021 Dec; 22(1):867. PubMed ID: 34857010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early clues regarding the pathogenesis of long-COVID.
    Peluso MJ; Deeks SG
    Trends Immunol; 2022 Apr; 43(4):268-270. PubMed ID: 35272932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
    Munblit D; Nicholson T; Akrami A; Apfelbacher C; Chen J; De Groote W; Diaz JV; Gorst SL; Harman N; Kokorina A; Olliaro P; Parr C; Preller J; Schiess N; Schmitt J; Seylanova N; Simpson F; Tong A; Needham DM; Williamson PR;
    Lancet Respir Med; 2022 Jul; 10(7):715-724. PubMed ID: 35714658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care.
    Parker AM; Brigham E; Connolly B; McPeake J; Agranovich AV; Kenes MT; Casey K; Reynolds C; Schmidt KFR; Kim SY; Kaplin A; Sevin CM; Brodsky MB; Turnbull AE
    Lancet Respir Med; 2021 Nov; 9(11):1328-1341. PubMed ID: 34678213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
    J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT.
    Bell ML; Catalfamo CJ; Farland LV; Ernst KC; Jacobs ET; Klimentidis YC; Jehn M; Pogreba-Brown K
    PLoS One; 2021; 16(8):e0254347. PubMed ID: 34347785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID.
    Chasco EE; Dukes K; Jones D; Comellas AP; Hoffman RM; Garg A
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring New Symptoms After COVID-19 Infection Among Primary Care Patients in New York City.
    Terlizzi K; Kutscher E; Yoncheva Y
    J Am Board Fam Med; 2021; 34(5):1014-1016. PubMed ID: 34535527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status.
    Xie Y; Bowe B; Al-Aly Z
    Nat Commun; 2021 Nov; 12(1):6571. PubMed ID: 34772922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long COVID Citizen Scientists: Developing a Needs-Based Research Agenda by Persons Affected by Long COVID.
    Ziegler S; Raineri A; Nittas V; Rangelov N; Vollrath F; Britt C; Puhan MA
    Patient; 2022 Sep; 15(5):565-576. PubMed ID: 35478078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
    Ryan FJ; Hope CM; Masavuli MG; Lynn MA; Mekonnen ZA; Yeow AEL; Garcia-Valtanen P; Al-Delfi Z; Gummow J; Ferguson C; O'Connor S; Reddi BAJ; Hissaria P; Shaw D; Kok-Lim C; Gleadle JM; Beard MR; Barry SC; Grubor-Bauk B; Lynn DJ
    BMC Med; 2022 Jan; 20(1):26. PubMed ID: 35027067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Covid: where we stand and challenges ahead.
    Mantovani A; Morrone MC; Patrono C; Santoro MG; Schiaffino S; Remuzzi G; Bussolati G;
    Cell Death Differ; 2022 Oct; 29(10):1891-1900. PubMed ID: 36071155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.